The PSDP provides a training environment in which talented young pediatricians address central problems in child health with the most current scientific tools. Ultimately, these pediatric scientists, dedicated to continuing careers in basic, translational, and clinical research, will translate research advances to improvements in clinical care for children. The PSDP also provides career development support for pediatricians committed to careers in academic medicine.

The PSDP is an intense postdoctoral experience in basic, translational, or clinical research training. Fellows conduct research in eminent laboratories in Canada and the USA. After completion of the clinical fellowship years, the first year of PSDP research training is funded by the Scholar’s sponsoring institution. The last two years of PSDP research training are funded by the Program. A sponsoring pediatric department supports the clinical fellowship apart from the circumstances described below. No patient care or clinical duties are allowed during the first two years of PSDP training unless requested at the time of application and approved by the Program Director prior to the PSDP training.

Applicants may request up to 10% clinical time in years 1 and 2, and allow up to 15% clinical time in year 3. Specifically, the 10% in years 1 and 2, should be designed around enhancing your research training, not just serving the clinical needs of your division and should have minimal impact on your protected research time. Justification must be given on how proposed clinical time will benefit research and career development as a physician-scientist.

The PSDP is sponsored by The Association of Medical School Pediatric Department Chairs (AMSPDC). In a unique collaborative arrangement, the program is funded by grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and numerous private agencies and foundations, including the American Academy of Pediatrics, the American Pediatric Society,  the March of Dimes, Burroughs Wellcome Fund, the Cystic Fibrosis Foundation, and Weill Cornell Medicine.